C7orf33

gene
On this page

Summary

C7orf33 (chromosome 7 open reading frame 33, HGNC:21724) is a protein-coding gene on chromosome 7q36.1, encoding Uncharacterized protein C7orf33 (Q8WU49).

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 8 total — 2 pathogenic, 1 likely-pathogenic
  • MANE Select transcript: NM_145304

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21724
Approved symbolC7orf33
Namechromosome 7 open reading frame 33
Location7q36.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000170279
Ensembl biotypeprotein_coding
Entrez202865

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000307003

RefSeq mRNA: 1 — MANE Select: NM_145304 NM_145304

CCDS: CCDS5890

Canonical transcript exons

ENST00000307003 — 3 exons

ExonStartEnd
ENSE00001133902148615327148615860
ENSE00001133910148590766148591129
ENSE00001172801148614042148614296

Expression profiles

Bgee: expression breadth tissue_specific, 9 present calls, max score 81.17.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0065 / max 9.3529, expressed in 1 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
818610.00651

Top tissues by expression

227 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.17gold quality
ganglionic eminenceUBERON:000402369.14gold quality
myocardiumUBERON:000234957.53gold quality
buccal mucosa cellCL:000233657.28gold quality
cartilage tissueUBERON:000241854.54gold quality
endothelial cellCL:000011554.05gold quality
gingivaUBERON:000182853.59gold quality
gingival epitheliumUBERON:000194953.36gold quality
heart right ventricleUBERON:000208053.07gold quality
trabecular bone tissueUBERON:000248352.21gold quality
tendon of biceps brachiiUBERON:000818846.88gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450245.14gold quality
ventricular zoneUBERON:000305344.50silver quality
amniotic fluidUBERON:000017344.31gold quality
synovial jointUBERON:000221743.77gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
pharyngeal mucosaUBERON:000035543.24gold quality
body of tongueUBERON:001187643.21gold quality
vastus lateralisUBERON:000137942.98gold quality
lower lobe of lungUBERON:000894942.92silver quality
quadriceps femorisUBERON:000137742.91gold quality
secondary oocyteCL:000065542.57gold quality
parotid glandUBERON:000183142.38gold quality
biceps brachiiUBERON:000150742.21gold quality
layer of synovial tissueUBERON:000761641.79gold quality
bone marrowUBERON:000237141.61gold quality
bone marrow cellCL:000209241.57silver quality
skeletal muscle tissueUBERON:000113441.48gold quality
superficial temporal arteryUBERON:000161441.33gold quality
palpebral conjunctivaUBERON:000181241.10gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

21 targeting C7orf33, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-3180-5P99.8269.122422
HSA-MIR-471999.7372.103329
HSA-MIR-130399.6569.771662
HSA-MIR-4666B99.6468.691282
HSA-MIR-443799.5265.291266
HSA-MIR-889-3P99.4069.762103
HSA-MIR-32-3P99.3668.202517
HSA-MIR-130A-5P99.3370.262623
HSA-MIR-488-5P99.2868.12821
HSA-MIR-5197-3P98.7167.051905
HSA-MIR-6852-3P98.5467.601468
HSA-MIR-138-5P98.4370.491292
HSA-MIR-499B-5P98.3568.39988
HSA-MIR-316698.2466.631223
HSA-MIR-4685-3P97.5567.351255
HSA-MIR-428797.5567.241247
HSA-MIR-10400-3P97.2964.66597
HSA-MIR-467497.2964.62597
HSA-MIR-568493.1764.85454

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Uncharacterized protein C7orf33Q8WU49 (reviewed: Q8WU49)

All UniProt accessions (2): Q8WU49, A0A090N8Y1

RefSeq proteins (1): NP_660347* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR041287DUF5548Family

Pfam: PF17702

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WU49-F132.200.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 34 (showing top): NKX25_02, TGACCTY_ERR1_Q2, TAL1ALPHAE47_01, AAAYRNCTG_UNKNOWN, CAGCTG_AP4_Q5, HFH8_01, OCT1_07, TGANTCA_AP1_C, HFH1_01, FREAC4_01, TAL1BETAE47_01, FOX_Q2, ER_Q6_02, TAL1BETAITF2_01, MIR889_3P

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

154 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C7orf33DRC11LA6NCM1570
C7orf33A0A087WTJ2A0A087WTJ2514
C7orf33ZNF425Q6IV72507
C7orf33ZBED10PQ96FA7507
C7orf33ZNF786Q8N393506
C7orf33ZNF783Q6ZMS7479
C7orf33LRRC61Q9BV99479
C7orf33KRABD3A5PL33478
C7orf33WDR86Q86TI4477
C7orf33ZC3HAV1LQ96H79475
C7orf33ZNF775Q96BV0448
C7orf33ZNF212Q9UDV6447
C7orf33TMEM213A2RRL7445
C7orf33ZNF862O60290435
C7orf33KLRG2A4D1S0433

IntAct

4 interactions, top by confidence:

ABTypeScore
C7orf33PSMG3psi-mi:“MI:0915”(physical association)0.400
C7orf33TNNC2psi-mi:“MI:0914”(association)0.350
INSRRIMOC1psi-mi:“MI:0914”(association)0.350

BioGRID (4): C7orf33 (Positive Genetic), ACTA2 (Affinity Capture-MS), TNNC2 (Affinity Capture-MS), PSMG3 (Affinity Capture-MS)

ESM2 similar proteins: A0A1P8NVU1, A0A7H0DN35, A4TSL2, B2K870, B4F0U2, B9VXI8, C9J3V5, D3ZF18, F5HHT4, H3BU77, J3QM76, O89941, P05901, P0C8D9, P0CAQ7, P0DJX6, P0DJX7, P0DQF3, P0DW17, P14345, P16722, P19564, P21601, P22834, P24034, P36868, P59037, P61475, P64976, P86523, P9WLE4, P9WLE5, Q02781, Q10027, Q1C0B5, Q1CCJ5, Q1HVB5, Q2V4N5, Q495D7, Q497P3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

8 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic1
Uncertain significance3
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
2425899NC_000007.13:g.(?146471343)(148544390_?)delPathogenic
833138NC_000007.14:g.(?147395589)(148847318_?)delPathogenic
146688GRCh38/hg38 7q35-36.1(chr7:145999194-148860586)x1Likely pathogenic

SpliceAI

289 predictions. Top by Δscore:

VariantEffectΔscore
7:148614041:GAA:Gacceptor_gain0.9900
7:148614038:CCA:Cacceptor_loss0.9800
7:148614039:CA:Cacceptor_loss0.9800
7:148614040:A:AGacceptor_gain0.9800
7:148614040:A:Gacceptor_loss0.9800
7:148614041:G:GGacceptor_gain0.9800
7:148614041:GA:Gacceptor_gain0.9800
7:148614041:GAAGC:Gacceptor_gain0.9700
7:148591127:AAGG:Adonor_loss0.9000
7:148591128:AGGTA:Adonor_loss0.9000
7:148591130:GTAA:Gdonor_loss0.9000
7:148591131:T:Gdonor_loss0.9000
7:148614022:T:Aacceptor_loss0.8700
7:148591130:G:GGdonor_gain0.8500
7:148614030:T:TAacceptor_gain0.8500
7:148614044:GCCA:Gacceptor_gain0.7900
7:148615466:A:Gacceptor_gain0.7800
7:148603077:G:GTdonor_gain0.7600
7:148614038:CCAGA:Cacceptor_gain0.7300
7:148614039:CAGA:Cacceptor_gain0.7200
7:148614040:AGAA:Aacceptor_gain0.7200
7:148614041:GAAG:Gacceptor_gain0.7200
7:148590904:A:Tdonor_gain0.7100
7:148591132:AA:Adonor_loss0.7000
7:148614044:GCC:Gacceptor_gain0.7000
7:148595197:C:CGdonor_gain0.6800
7:148591128:AG:Adonor_gain0.6700
7:148591129:GG:Gdonor_gain0.6700
7:148593841:GC:Gdonor_gain0.6700
7:148592238:C:Adonor_gain0.6600

AlphaMissense

1140 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:148614081:T:CF82L0.939
7:148614083:T:AF82L0.939
7:148614083:T:GF82L0.939
7:148614129:T:CF98L0.936
7:148614131:T:AF98L0.936
7:148614131:T:GF98L0.936
7:148591097:T:CF58L0.922
7:148591099:T:AF58L0.922
7:148591099:T:GF58L0.922
7:148591098:T:CF58S0.890
7:148591104:T:CL60S0.875
7:148591065:T:AV47D0.851
7:148614172:T:CI112T0.832
7:148614282:A:CS149R0.802
7:148614284:T:AS149R0.802
7:148614284:T:GS149R0.802
7:148590970:G:CW15C0.796
7:148590970:G:TW15C0.796
7:148591071:T:AV49D0.775
7:148614130:T:CF98S0.771
7:148614253:T:AL139H0.755
7:148614125:G:CW96C0.754
7:148614125:G:TW96C0.754
7:148615379:T:CI171T0.749
7:148591098:T:GF58C0.734
7:148591104:T:GL60W0.734
7:148614172:T:GI112S0.728
7:148614258:T:GY141D0.728
7:148614263:G:CK142N0.725
7:148614263:G:TK142N0.725

dbSNP variants (sampled 300 via entrez): RS1000022594 (7:148592843 T>TA), RS1000239537 (7:148589526 C>T), RS1000311687 (7:148614405 G>A), RS1000398560 (7:148596148 T>C), RS1000461173 (7:148591176 A>C), RS1000548085 (7:148615771 A>G), RS1000619918 (7:148614149 G>A,C), RS1000707551 (7:148610171 T>G), RS1000802962 (7:148597227 A>G), RS1000827754 (7:148608813 T>C), RS1001128823 (7:148597584 A>G), RS1001304010 (7:148603936 C>A,T), RS1001310141 (7:148613358 C>A,T), RS1001419840 (7:148600967 T>C), RS1001497150 (7:148611359 A>G)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:610042

GenCC curated gene-disease

Mondo (1): cortical dysplasia-focal epilepsy syndrome (MONDO:0012400)

Orphanet (2): CNTNAP2-related developmental and epileptic encephalopathy (Orphanet:163681), OBSOLETE: Pitt-Hopkins-like syndrome (Orphanet:221150)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST009391_201Metabolite levels5.000000e-06
GCST009391_5Metabolite levels1.000000e-06
GCST012490_516Femur bone mineral density x serum urate levels interaction4.000000e-10
GCST90000015_11Parkinson’s disease motor subtype (tremor to postural instability/gait difficulty score ratio)3.000000e-06

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0010488glycerol-3-phosphate measurement
EFO:0007813cotinine measurement
EFO:0004531urate measurement
EFO:0600011Parkinson’s disease symptom measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
C567657Cortical Dysplasia-Focal Epilepsy Syndrome (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases expression, increases methylation2
Folic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.